Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Mollejo

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Blood|January 4, 2003
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutationsFrancisca I Camacho, Patrocinio Algara, Antonia Rodríguez, et al.
Histopathology|October 12, 2013
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosisJosé M Morgado, Omar Perbellini, Ryan C Johnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 19, 2022
Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell ClonalityTiago Azenha Rama, Inés Torrado, Ana Filipa Henriques, et al.
The American Journal of Pathology|January 27, 2004
Building an outcome predictor model for diffuse large B-cell lymphomaAna-Isabel Sáez, Antonio-José Sáez, María-Jesús Artiga, et al.
Clinical Nuclear Medicine|July 16, 2019
18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for GliomasAna María García Vicente, Julian Pérez-Beteta, Mariano Amo-Salas, et al.
Leukemia & Lymphoma|June 27, 2013
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical useCarlos Montalban, Victor Abraira, Luca Arcaini, et al.
British Journal of Haematology|August 29, 2012
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 casesCarlos Montalbán, Víctor Abraira, Luca Arcaini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2011
Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cellsFrancisca I Camacho, Carmen Bellas, Cesáreo Corbacho, et al.
Frontiers in Cell and Developmental Biology|August 27, 2021
Epigenetic Deregulation of the Histone Methyltransferase <i>KMT5B</i> Contributes to Malignant Transformation in GlioblastomaVirginia López, Juan Ramón Tejedor, Antonella Carella, et al.
Blood|October 24, 2002
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarraysJuan F García, Francisca I Camacho, Manuel Morente, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Blood|January 4, 2003
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutationsFrancisca I Camacho, Patrocinio Algara, Antonia Rodríguez, et al.
Histopathology|October 12, 2013
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosisJosé M Morgado, Omar Perbellini, Ryan C Johnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 19, 2022
Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell ClonalityTiago Azenha Rama, Inés Torrado, Ana Filipa Henriques, et al.
The American Journal of Pathology|January 27, 2004
Building an outcome predictor model for diffuse large B-cell lymphomaAna-Isabel Sáez, Antonio-José Sáez, María-Jesús Artiga, et al.
Clinical Nuclear Medicine|July 16, 2019
18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for GliomasAna María García Vicente, Julian Pérez-Beteta, Mariano Amo-Salas, et al.
Leukemia & Lymphoma|June 27, 2013
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical useCarlos Montalban, Victor Abraira, Luca Arcaini, et al.
British Journal of Haematology|August 29, 2012
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 casesCarlos Montalbán, Víctor Abraira, Luca Arcaini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2011
Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cellsFrancisca I Camacho, Carmen Bellas, Cesáreo Corbacho, et al.
Frontiers in Cell and Developmental Biology|August 27, 2021
Epigenetic Deregulation of the Histone Methyltransferase <i>KMT5B</i> Contributes to Malignant Transformation in GlioblastomaVirginia López, Juan Ramón Tejedor, Antonella Carella, et al.
Blood|October 24, 2002
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarraysJuan F García, Francisca I Camacho, Manuel Morente, et al.
Pageof 12